📰 Controlled Trials News
Page 2 - Controlled Trials News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Controlled Trials. Real-time updates on events, politics, business and more.
February 20, 2024
Key CAPA predictors are liver disease, hematological malignancies, COPD, CVD, IMV, RRT, and corticosteroids or IL-6 inhibitor use for COVID-19.
February 8, 2024
Corticosteroids can reduce the need for mechanical ventilation, incidence of shock, and length of hospital stay, especially for younger patients with community-acquired pneumonia.
February 2, 2024
A systematic review suggests practitioners using enhanced empathy improves patient satisfaction, but research is hindered by inadequate reporting and heterogeneity.
February 1, 2024
The association between biomarkers of cholesterol homeostasis and mortality in critically ill patients.
January 30, 2024
Curious about a morning ritual that supercharges health? Discover the secrets of ginger juice – your new wellness elixir! Why the buzz? Find out now!
January 29, 2024
Objective To evaluate the comparative efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on glycaemic control, body weight, and lipid profile in adults with type 2 diabetes. Design Systematic review and network meta-analysis. Data sources PubMed, Web of Science, Cochrane Central Register of Controlled Trials (CENTRAL), and Embase from database inception to 19 August 2023. Eligibility criteria for selecting studies Eligible randomised controlled trials enrolled adults wit...
January 29, 2024
A meta-analysis explored the individual components of cognitive behavioral therapy for insomnia (CBT-I) and suggested that cognitive restructuring, stimulus control and sleep restrictions provide the more benefits to patients.
January 19, 2024
A new study found critical components of CBT-I are cognitive restructuring, third-wave components, sleep restrictions, and stimulus control.
January 4, 2024
Patients with pulmonary arterial hypertension (PAH) had similar efficacy and safety profile when taking either oral Treprostinil or selexipag, indicating that Treprostinil would be an adequate replacement.
December 22, 2023
Results from the systematic review and meta-analysis demonstrated the positive effect of DAA therapy on overall survival, HCC-free survival, and liver function among patients with HCV decompensated cirrhosis compared to a non-DAA control group.